Original Article

The International Diabetes Management Practices Study (IDMPS) - Turkey’s 5th Wave Results

Volume 20 · Issue 3 Publish Date: September 1, 2016
Full Text PDF
DOI
Hasan İlkova
İstanbul University Cerrahpaşa Faculty of Medicine, Department of Endocrinology and Metabolism, İstanbul, Turkey
Taner Damcı
İstanbul University İstanbul Faculty of Medicine, Department of Endocrinology and Metabolism, İstanbul, Turkey
Kubilay Karşıdağ
Dokuz Eylül University Faculty of Medicine, Department of Endocrinology and Metabolism, İzmir, Turkey
Abdurrahman Çömlekçi
Gazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey
Göksun Ayvaz
The International Diabetes Management Practices Study
İlkova, H., Damcı, T., Karşıdağ, K., Çömlekçi, A., & Ayvaz, G. (2016). The International Diabetes Management Practices Study (IDMPS) - Turkey’s 5th Wave Results. Endocrinology Research and Practice, 20(3), 88–96. https://doi.org/10.4274/tjem.3120
Full Text Full Text PDF

Abstract

ABSTRACT

Purpose: The prevalence of type 2 diabetes mellitus (T2DM) is increasing in Turkey due to rising obesity rates, sedentary life styles and Turkey’s aging population; up-to-date and standardized data collection is required for the global fight against diabetes. The data collected from Turkey during the 5th wave of a multinational, multi-center and observational study are evaluated in this article.
Material and Method: The International Diabetes Management Practices Study (IDMPS) which is an international, observational multicenter, cross-sectional study, evaluated demographic and clinical characteristics of diabetic patients, treatment modalities, complications, cardiovascular risk factors and also reported the results of the patient health questionnaire (PHQ-9).
Results: This study consisted of 842 T2DM and 115 Type 1 diabetes mellitus (T1DM) patients and was carried out by 94 doctors in Turkey between December 13th 2011 and January 26th 2012. Data revealed that 52% of patients were treated with oral anti-diabetic (OAD) drugs only, 29% were treated with OAD + insulin, and 18% of subjects were treated with insulin alone. 88% of T2DM patients had at least one microvascular complication and 99% had at least one cardiovascular risk factor. Only 27% of T1DM and 28% of T2DM patients reached the target hemoglobin A1c value of <7%. PHQ-9 results revealed that majority of patients did not have a depressive disorder (79% for both T1DM and T2DM).
Discussion: Attainment and maintenance of the internationally recommended optimal glycemic values is essential for effective treatment of diabetes. Almost 72% of T2DM patients in Turkey did not reach the target values. Diabetes patient education aiming to provide the knowledge necessary to make and maintain lifestyle changes is necessary.

Article Info
Published In
Journal Endocrinology Research and Practice
Volume / Issue Volume 20 · Issue 3
Pages 88-96
History
Published Online September 1, 2016
Copyright
Affiliations
Hasan İlkova
İstanbul University Cerrahpaşa Faculty of Medicine, Department of Endocrinology and Metabolism, İstanbul, Turkey
Taner Damcı
İstanbul University İstanbul Faculty of Medicine, Department of Endocrinology and Metabolism, İstanbul, Turkey
Kubilay Karşıdağ
Dokuz Eylül University Faculty of Medicine, Department of Endocrinology and Metabolism, İzmir, Turkey
Abdurrahman Çömlekçi
Gazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkey
Göksun Ayvaz
The International Diabetes Management Practices Study
Cite this Article
İlkova, H., Damcı, T., Karşıdağ, K., Çömlekçi, A., & Ayvaz, G. (2016). The International Diabetes Management Practices Study (IDMPS) - Turkey’s 5th Wave Results. Endocrinology Research and Practice, 20(3), 88–96. https://doi.org/10.4274/tjem.3120
Outlines